GlassScriptPhysician profile
Jordan L Marentette
NPI 1609514306
$1,396.56
in general payments reported to CMS, 2019-2025
17 companies · $39.51 in 2025
The $39.51 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $672 · 2024: $549 · 2025: $39.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $211.47 | 2023-2024 | Infuse, Xiidra, Miebo |
| Apellis Pharmaceuticals, INC. | $202.91 | 2023 | Syfovre |
| Alimera Sciences, INC. | $144.53 | 2022-2024 | Iluvien, Yutiq |
| Dompe US, INC. | $127.42 | 2023-2024 | Oxervate |
| Oyster Point Pharma, INC. | $122.07 | 2023 | Tyrvaya |
| Abbvie INC. | $120.31 | 2022-2025 | |
| Coopervision INC. | $109.12 | 2024 | Misight Contact Lens |
| Horizon Therapeutics Plc | $105.36 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $56.51 | 2024 | Xdemvy |
| Alcon Vision LLC | $33.84 | 2022-2024 | Clareon |
| Carl Zeiss Meditec, INC. | $33.00 | 2022 | |
| Biotissue Holdings INC. | $28.72 | 2022 | |
| Astellas Pharma US INC | $25.92 | 2023 | |
| Harrow Eye, LLC | $24.07 | 2024 | Vevye |
| Glaukos Corporation | $20.96 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $16.55 | 2024 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $13.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Marentette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.